Development and internal validation of a nomogram for predicting short-term functional improvement after pharmacological treatment in severe symptomatic lumbar disk herniation - Scorecard - MDSpire
Advertisement
Development and internal validation of a nomogram for predicting short-term functional improvement after pharmacological treatment in severe symptomatic lumbar disk herniation
Clinical Scorecard: Creation and internal validation of a nomogram to forecast short-term functional enhancement following pharmacological intervention in severe symptomatic lumbar disk herniation
At a Glance
Category
Detail
Condition
Key Mechanisms
Pharmacological treatment options include Chinese patent medicine (CPM), non-steroidal anti-inflammatory drugs (NSAIDs), acetaminophen, and muscle relaxants.
Target Population
Care Setting
Key Highlights
Nomogram developed to predict 14-day improvement in Oswestry Disability Index (ODI) with noted limitations.
Guideline-Based Recommendations
Diagnosis
Management
Pharmacological treatment options include NSAIDs, acetaminophen, muscle relaxants, and CPM as per North American Spine Society guidelines.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
199 patients with severe LDH from 13 centers.
Treatment response varies; nomogram assists in predicting individual outcomes.
Clinical Best Practices
Utilize the nomogram for pre-treatment risk stratification, noting the need for external validation.
In this procedural case review, vascular surgeon Dr. Samuel Steerman and neurosurgeon Dr. Shannon Clark collaborate to perform an anterior lumbar interbody fusion (ALIF).
